Alzheimer's Disease (AD) Mechanism: GLP-1 and GIP receptor activation enhance neurogenesis, reduce amyloid- (A) deposition, and mitigate neuroinflammation
Neurological support : NAC regulates glutamate and brain chemistry, glutathione shields neurons from oxidative stress
Substitutes: Oral taurine supplements
Healthcare providers may consider: Bacterial culture if infection is suspected Temporary discontinuation of semaglutide to assess symptom resolution Referral to allergy/immunology for suspected hypersensitivity reactions For type 2 diabetes patients only, alternative GLP-1 receptor agonist formulations (such as oral semaglutide/Rybelsus) if injection site reactions are recurrent and problematic Patients with confirmed hypersensitivity to semaglutide should not continue the medication
Less commonly, people taking GLP-1 medications can experience problems with the pancreas, stomach, intestines, gallbladder, or kidneys
Non-motor symptoms in Parkinsons disease